Skip to main content

Dierks Jeffrey's Form 4 filing

Harmony Biosciences Holdings, Inc. (HRMY) · filed Aug 23, 2022

Accession no.
0001415889-22-008969
Filed
Aug 23, 2022
Trade date
Aug 22, 2022
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.36M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Dierks JeffreyCIK 0001821102Officer (CHIEF COMMERCIAL OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 22, 2022Common StockMOption exerciseAcquired+28,971$24.00+$695,30428,971Direct
Aug 22, 2022Common StockSSaleDisposed−26,650$46.95−$1,251,217.52,321Direct
Aug 22, 2022Common StockSSaleDisposed−2,321$47.56−$110,386.760Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 22, 2022Common StockMOption exerciseDisposed−28,971$0.00$086,914Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)